A randomized, double-blind, placebo-controlled phase IIa trial of efruxifermin for patients with compensated NASH cirrhosis

202295 citationsJournal Articlegold Open Access

Authors

NCT03976401.

Good health and well-being

Published in: JHEP Reports

Volume 5, Issue 1, pp. 100563-100563

Field-Weighted Citation Impact: 13.57